isoxazoles has been researched along with r 61837 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| al-Nakib, W; Andries, K; Dearden, C; Tyrrell, DA; Woestenborghs, R | 1 |
| Andries, K; Dewindt, B; van Eemeren, K | 1 |
| Andries, K; Chapman, MS; Diana, GD; Gong, ZX; Kim, KH; Kremer, MJ; Minor, I; Oliveira, MA; Rossmann, MG; Willingmann, P | 1 |
3 other study(ies) available for isoxazoles and r 61837
| Article | Year |
|---|---|
Drug resistant rhinoviruses from the nose of experimentally treated volunteers.
Topics: Antiviral Agents; Chalcone; Drug Resistance, Microbial; Flavonoids; Humans; Isoxazoles; Microbial Sensitivity Tests; Nose; Pyridazines; Rhinovirus | 1989 |
Antiviral capsid-binding compounds can inhibit the adsorption of minor receptor rhinoviruses.
Topics: Adsorption; Antiviral Agents; Capsid; Chalcone; Chalcones; Flavonoids; HeLa Cells; Humans; Isoxazoles; Mutation; Protein Conformation; Pyridazines; Receptors, Virus; Rhinovirus | 1994 |
A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A.
Topics: Amino Acid Sequence; Antiviral Agents; Binding Sites; Capsid; Conserved Sequence; Drug Design; Isoxazoles; Models, Molecular; Molecular Sequence Data; Pyridazines; Rhinovirus; Sequence Alignment; Serotyping; Structure-Activity Relationship | 1993 |